Investec Asset Management North America Inc. reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% during the first quarter, according to its most recent filing with the SEC. The firm owned 78,312 shares of the healthcare conglomerate’s stock after selling 711 shares during the period. UnitedHealth Group comprises 2.4% of Investec Asset Management North America Inc.’s portfolio, making the stock its 8th largest position. Investec Asset Management North America Inc.’s holdings in UnitedHealth Group were worth $12,844,000 at the end of the most recent quarter.
Several other large investors have also recently modified their holdings of the company. Patriot Financial Group Insurance Agency LLC raised its position in UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares in the last quarter. Cribstone Capital Management LLC raised its position in UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 125 shares in the last quarter. Kings Point Capital Management raised its position in UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares in the last quarter. Founders Capital Management bought a new position in UnitedHealth Group during the first quarter valued at approximately $135,000. Finally, Parkside Financial Bank & Trust raised its position in UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares in the last quarter. 86.21% of the stock is currently owned by hedge funds and other institutional investors.
Shares of UnitedHealth Group Incorporated (NYSE UNH) traded down 0.98% during trading on Friday, hitting $190.82. The stock had a trading volume of 2,858,501 shares. The stock has a market cap of $184.50 billion, a P/E ratio of 22.92 and a beta of 0.64. The stock’s 50 day moving average price is $190.49 and its 200-day moving average price is $175.87. UnitedHealth Group Incorporated has a one year low of $132.39 and a one year high of $196.04.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. During the same period last year, the business earned $1.96 EPS. The company’s revenue was up 7.7% on a year-over-year basis. Analysts expect that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.57%. UnitedHealth Group’s payout ratio is 35.13%.
COPYRIGHT VIOLATION WARNING: This story was first published by BNB Daily and is the property of of BNB Daily. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://www.baseball-news-blog.com/2017/08/19/unitedhealth-group-incorporated-unh-shares-sold-by-investec-asset-management-north-america-inc-updated.html.
Several research firms recently commented on UNH. Jefferies Group LLC reiterated a “buy” rating and issued a $215.00 price target on shares of UnitedHealth Group in a research report on Friday. Morgan Stanley lifted their price target on UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Thursday. Cowen and Company restated an “outperform” rating and set a $220.00 target price (up previously from $175.00) on shares of UnitedHealth Group in a research report on Friday, August 11th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 target price for the company in a research report on Tuesday, August 1st. Finally, Oppenheimer Holdings, Inc. restated an “outperform” rating and set a $205.00 target price (up previously from $203.00) on shares of UnitedHealth Group in a research report on Friday, July 21st. One research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and an average price target of $203.41.
In related news, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total transaction of $990,219.60. Following the sale, the director now directly owns 60,516 shares in the company, valued at approximately $10,816,629.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total transaction of $913,200.00. Following the sale, the director now owns 75,735 shares in the company, valued at $13,832,240.40. The disclosure for this sale can be found here. Insiders sold a total of 15,540 shares of company stock worth $2,873,320 over the last 90 days. Company insiders own 0.89% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.